| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2005;36:2670.)
© 2005 American Heart Association, Inc.
Original Contributions |
From the Sección de Neurología (T.d.S., M.M.M., J.D., C.C., M.P.), Hospital Severo Ochoa, Leganés; Servicio de Medicina Interna (R.B.), Hospital de Alcorcón; and Servicio de Neurología (J.V.), Hospital de la Princesa, Madrid, Spain.
Correspondence to Teodoro del Ser, MD, Sección de Neurología, Hospital Severo Ochoa, Avda, Orellana s/n, Leganés, 28911 Madrid, Spain. E-mail tdeserq{at}meditex.es
Background and Purpose Cognitive decline occurs in
30% of stroke patients. Acute risk factors have been identified, but long-term risk has not been examined in large samples. The purpose of this research was to determine factors associated with the progression of cognitive impairment after stroke.
Methods Consecutive stroke patients (193) without previous dementia were assessed 3 months after stroke with an extensive neuropsychological battery and diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition criteria and the Clinical Dementia Rating as normal (139), cognitive decline without dementia (18), or dementia (18 mild, 10 moderate, and 8 severe). After a 24-month follow-up, they were classified as stable, progressing, or improving, according to change in Clinical Dementia Rating score. The determinants of progression of cognitive decline were ascertained by logistic regression analysis of all clinical, neuroimaging, and complementary data.
Results Cognitive status at 24 months was stable in most cases (151; 78.2%), decline progressed in 27 (14%; 6 demented and 21 nondemented), and improved in 15 (7.8%; 7 demented and 8 nondemented). Seven nondemented patients became demented at 24 months, and 5 demented became nondemented. The age (odds ratio [OR], 1.05; 95% CI, 1.01 to 1.1), mental decline before stroke (OR, 1.14; 95% CI, 1.02 to 1.27), number of prescribed drugs (OR, 1.34; 95% CI, 1.05 to 1.72), diastolic blood pressure on admission (OR, 0.96; 95% CI, 0.93 to 0.99), and episodes of hypotension during admission (OR, 7.61; 95% CI, 1.11 to 52.1) were significantly associated with cognitive deterioration.
Conclusions Cognition is rather stable for 2 years after stroke. Both progression and improvement of cognitive impairment are frequent in demented patients. Age, previous cognitive decline, polypharmacy, and hypotension during admission are risk factors for progression.
Key Words: vascular cognitive impairment dementia risk factor longitudinal study
This article has been cited by other articles:
![]() |
C. H Rojas-Fernandez and P. Moorhouse Current Concepts in Vascular Cognitive Impairment and Pharmacotherapeutic Implications Ann. Pharmacother., July 1, 2009; 43(7): 1310 - 1323. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Serrano, J. Domingo, E. Rodriguez-Garcia, M.-D. Castro, and T. del Ser Frequency of Cognitive Impairment Without Dementia in Patients With Stroke: A Two-Year Follow-Up Study Stroke, January 1, 2007; 38(1): 105 - 110. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. K. Srikanth, S. J. Quinn, G. A. Donnan, M. M. Saling, and A. G. Thrift Long-Term Cognitive Transitions, Rates of Cognitive Change, and Predictors of Incident Dementia in a Population-Based First-Ever Stroke Cohort Stroke, October 1, 2006; 37(10): 2479 - 2483. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |